The aim of this study was to develop and validate a tNGS approach to genotype patients with HPA through the simultaneous detection of sequence alterations and CNVs in seven genes implicated in Phe metabolism (PAH, GCH1, PTS, QDPR, PCBD1, DNAJC12, SPR). This evidence concerns the gene SPR and pulmonary arterial hypertension.